Preventing Melanoma with the Help of Occupational Physicians
- Authors
-
-
Alberto Modenese
Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy
-
- Keywords:
- Malignant melanoma, occupational cancer, solar radiation, outdoor work, UV exposure prevention.
- Abstract
-
Melanoma incidence is increasing constantly worldwide in recent years: 132,000 melanoma skin cancers occur globally each year (WHO-INTERSUN). Despite this, no adequate evidence regarding the role of cumulative solar UV exposure in inducing the skin cancer has been provided. Recently, some studies appear to indicate that, also in patients with melanoma history, the habit of completely avoiding sun exposure is not a positive prognostic factor. According to IARC monograph published in 2012, evidences regarding UV risk factors for melanoma are the intermittent UV exposure with recurrent sunburns, especially in childhood and adolescence.
According to these findings, various studies on occupational exposure to solar radiation (SR) failed to find an association between the performance of an outdoor job and the risk of melanoma. Recently, in Italy melanoma due to SR exposure has been erased from the national list of occupational diseases (D.P.R. 1124/65, last modification in 2014). But, in Europe an occupational health surveillance is needed for workers exposed to Artificial UV radiation according to EU Directive 2006/25/CE, and a skin examination for these workers is suggested, but quite paradoxically there are not similar indications for workers exposed to natural UV radiation.
Considering the great number of outdoor workers employed in Europe, at least 14 million according to OSHA, and worldwide, the consideration of occupational solar radiation exposure as a specific professional risk requiring the health surveillance of exposed workers will be very helpful in order to prevent melanoma and other UV related diseases.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 29-10-2016
- Issue
- Vol. 5 No. 4 (2016)
- Section
- Articles
How to Cite
Similar Articles
- A. Sakunpak, K. Matsunami, H. Otsuka, P. Panichayupakaranant, Isolation of Chamuangone, a Cytotoxic Compound against Leishmania major and Cancer Cells from Garcinia cowa Leaves and its HPLC Quantitative Determination Method , Journal of Cancer Research Updates: Vol. 6 No. 2 (2017)
- Fabio Franceschini Mitri, Advances of the Nanotechnology in Targeted Nanomedicines for Treatment of Bone Cancers and Diseases , Journal of Cancer Research Updates: Vol. 10 (2021)
- Tatjana P. Stanojkovic, Sanja Milovic, A Marine Natural Products as Modulators of Multidrug Resistance , Journal of Cancer Research Updates: Vol. 9 No. 1 (2020)
- Ilkay Cinar, Risk of Malignancy in Bethesda Category III Thyroid Nodules with Nuclear Atypia: A Retrospective Study Based on Thyroidectomy Findings , Journal of Cancer Research Updates: Vol. 15 No. 1 (2026)
- You-Qiu Xue, Ke-Jun Cheng, Jian-Ge Qiu, Xiao-Long Mei, Wen-Ji Zhang, Qi-Wei Jiang, Wu-Ming Qin, Yang Yang, Di-Wei Zheng, Yao Chen, Meng-Ning Wei, Dong-Mei Huo, Xing Wei, Zhi Shi, Antioxidant and Anticancer Activities of Raspberry Extracts , Journal of Cancer Research Updates: Vol. 4 No. 2 (2015): Special Issue - Natural Products for Cancer Prevention and Treatment
- S. Simonida Crvenkova, Maja Popova, Concomitant Treatment for Brain Metastases in Non-Small Cell Lung Cancer Patients: Our Clinical Experience , Journal of Cancer Research Updates: Vol. 5 No. 1 (2016)
- Wifaq Siam, Mona Ellaithi, Hind M. AbuShama, Abdulrahman Mujalli, Shakir Idris, Alaa Siddiq, Osama Mohamed Khair, Dania A. Albader, Faris M. Elmahdi, Clinicopathological Features and RB1 Gene Polymorphism in Sudanese Retinoblastoma Patients , Journal of Cancer Research Updates: Vol. 14 (2025)
- Ananda M. Chakrabarty, COMMENTARY: BRCA1/2 Mutations, Vulnerability to Breast/Ovarian Cancer, and Current and Future Treatment Modalities , Journal of Cancer Research Updates: Vol. 5 No. 2 (2016)
- Najia Mansoor, Rafeeq Alam Khan, Johannes Schueller, Dagmar Ettlinge, Philipp Buchner, Martin Czejka, Tasneem Ahmad, Irinotecan (CamptoR) Pharmacokinetics and Metabolism in Patients with Elevated Serum Bilirubin Levels , Journal of Cancer Research Updates: Vol. 5 No. 2 (2016)
- Igor V. Maev, Dmitry N. Andreev, Yuriy A. Kucheryavyy, Diana T. Dicheva, Neuroendocrine Tumors of the Pancreas: Molecular Pathogenesis and Perspectives on Targeted Therapies , Journal of Cancer Research Updates: Vol. 3 No. 3 (2014)
You may also start an advanced similarity search for this article.